Pathologies and Treatments

Intraocular hemorrhage or ocular hemorrhage, also called vitreous hemorrhage, is bleeding inside the vitreous cavity. This is the internal area of the eye.

The vitreous is a gelatinous and transparent substance that occupies two-thirds of the ocular volume. It is composed of 99% water. It borders posteriorly with the retina and anteriorly with the lens and the ciliary body.

The most frequent cause of intraocular hemorrhage is diabetic retinopathy, responsible for 50% of cases. Other common causes are rhegmatogenous retinal detachment and posterior vitreous detachment.

It can also be caused by obstruction of the central retinal vein. These conditions are responsible for 95% of cases of spontaneous vitreous hemorrhage.

Symptoms

The main symptom is a sudden loss of visual acuity that occurs over a few minutes. Depending on the intensity of the hemorrhage, the vision deficit may be complete, with total or partial blindness.

Treatments

Since the causes that produce vitreous hemorrhage are very diverse, a single treatment cannot be established for all patients. The treatment must be individualized, depending on the origin of the hemorrhage, its severity, and the patient’s personal circumstances.

If the hemorrhage is mild, it may resolve spontaneously, requiring only the passage of time, although full recovery of vision may take several months.

Other times, after a period of waiting, a surgical procedure called vitrectomy is recommended, which consists of removing the vitreous humor through minimally invasive micro-incision surgery.

Depending on the cause that originated the vitreous hemorrhage, other treatments may need to be added, such as the application of laser or the administration of intravitreal injections.

Medicina regenerativa: Endoret

Con el tratamiento de medicina regenerativa Endoret propiciamos la reparación de la superficie ocular afectada por la sequedad ocular. Se trata de un plasma rico en factores de crecimiento para el tratamiento de las lesiones de la superficie ocular elaborado a partir de la sangre del mismo paciente. Con esta formulación individualizada se consigue una tolerancia completa y una efectividad óptima. Esta opción terapéutica revolucionaria es muy eficaz en casos de defectos epiteliales persistentes o úlceras corneales. Asimismo se puede aplicar después de una cirugía refractiva corneal, una cirugía ocular o en el Síndrome de Sjögren.

Procedures

Medicina regenerativa: Endoret

Con el tratamiento de medicina regenerativa Endoret propiciamos la reparación de la superficie ocular afectada por la sequedad ocular. Se trata de un plasma rico en factores de crecimiento para el tratamiento de las lesiones de la superficie ocular elaborado a partir de la sangre del mismo paciente. Con esta formulación individualizada se consigue una tolerancia completa y una efectividad óptima. Esta opción terapéutica revolucionaria es muy eficaz en casos de defectos epiteliales persistentes o úlceras corneales. Asimismo se puede aplicar después de una cirugía refractiva corneal, una cirugía ocular o en el Síndrome de Sjögren.

Dr. Jordi Monés,

M.D. PhD

Número de Col·legiat COMB: 22.838

Director. Doctor of Medicine and Surgery. Specialist in Ophthalmology. Specialist in Retina, Macula, and Vitreous.

If you found this interesting, feel free to share it here:

Last modified: 26/08/2025
Scroll to Top
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.